Lateral Soft Tissue Release for Bunions
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether adding a lateral soft tissue release (LSTR) to a common bunion surgery, known as Chevron osteotomy, improves foot alignment without additional complications. Participants will be divided into two groups: one will undergo the standard surgery, while the other will receive the surgery with the added LSTR step. The trial aims to determine which method offers better correction for bunions. It seeks individuals over 18 with mild to moderate bunions that may benefit from the surgery. As an unphased trial, this study provides participants the chance to contribute to valuable research that could enhance surgical outcomes for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this surgical technique is safe for bunion correction?
Research shows that adding a lateral soft tissue release (LSTR) to Chevron osteotomy, a common bunion surgery, is generally safe. Studies on this combination have shown mixed benefits, but no major reports of serious side effects from the LSTR procedure itself have emerged. This indicates that patients usually tolerate it well. Surgeons have performed this surgery for a long time, and while earlier reports mentioned possible complications, these are rare. Therefore, patients considering joining the trial can feel reassured about the procedure's safety.12345
Why are researchers excited about this trial?
Researchers are excited about the Chevron osteotomy with lateral soft tissue release (LSTR) for bunions because it adds a new dimension to the standard surgical approach. Most bunion surgeries, like the traditional Chevron osteotomy, primarily focus on bone realignment. However, the addition of LSTR targets the soft tissue structures, which may help in better correcting the bunion deformity and potentially reducing recurrence rates. By addressing both bone and soft tissue, this method could offer improved outcomes for patients, making it a promising advancement in bunion treatment.
What evidence suggests that a lateral soft tissue release is effective for bunion correction?
This trial will compare the outcomes of Chevron osteotomy bunion surgery with and without lateral soft tissue release (LSTR). Research has shown that combining a Chevron osteotomy with LSTR can lead to positive outcomes for bunion correction, particularly in cases of moderate to severe hallux valgus, where the big toe points inward. Some studies suggest this combination might improve the alignment of the big toe and the space between the first and second toe bones more effectively than a Chevron osteotomy alone. However, results vary, with some research showing benefits and others showing little difference. The treatment aims to straighten the big toe and reduce pain by addressing the soft tissue around the joint. Overall, this approach is being evaluated for its potential to improve surgical results without adding complications.24678
Are You a Good Fit for This Trial?
This trial is for adults over 18 with mild to moderate bunions. Participants must be able to consent and are selected by study physicians as candidates for Chevron osteotomy, a type of foot surgery. People who don't meet the specific medical criteria or can't follow the trial procedures will be excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Chevron osteotomy bunion surgery with or without lateral soft tissue release (LSTR)
Follow-up
Participants are monitored for safety and effectiveness after surgery, with surveys and x-rays at 3, 6, and 12 months
What Are the Treatments Tested in This Trial?
Interventions
- Chevron Osteotomy with Lateral Soft Tissue Release
Chevron Osteotomy with Lateral Soft Tissue Release is already approved in United States, European Union for the following indications:
- Mild to moderate bunions
- Hallux valgus deformity
- Mild to moderate bunions
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Methodist Hospital Research Institute
Lead Sponsor